Urology Devices Market Size, Share, By Product {[Surgical Instruments (Catheter Introducers and Needles & Needle Holder, Forceps, Scissors, and Others), Devices [Diagnostic Devices (Endoscopes, Urodynamic System, Endovision & Imaging System, and Others), Surgical Devices (Laser & Lithotripsy Devices, Robotic System, Stents, and Others), and Consumables (Dialysis Consumables, Catheters, Surgical Dissectors, Guidewires, and Others)]}, Application (Benign Prostatic Hyperplasia , Prostate Cancer, Urinary Stones, Urinary Incontinence, and Others), End-User (Hospitals & Clinics, Dialysis Centers, Ambulatory Clinics, and Others) and Region - Trends, Analysis, and Forecast till 2035

• By 2035, urology devices market size is expected to increase at a rate of USD 81.6 Billion.
• Urology devices market size was valued at USD 37.2 Billion, in 2024.
• The target market is expanding at a CAGR 8.2%.

Urology devices are the instruments and tools used to diagnose and treat diseases & disorders of urinary system (such as kidneys, ureters, & urethra) and male reproductive organs. These devices consist of urodynamic systems, urology robotic system, laser & lithotripsy devices used to diagnostic bladder and urethra-related diseases. Urology devices can be used for diagnostic purposes, surgical interventions, or to assist in the treatment and management of various urological conditions.

The increasing prevalence of kidney stones, bladder cancer, prostate cancer and chronic kidney diseases, leading to urology devices market growth. The growing demand for single-use cystoscopes and the rising collaboration between key players, are anticipated to boost urology devices market growth. The global aging population, new innovation in minimally invasive surgeries, and development of smart urology devices, is a significant driver for urology devices market growth.

Growing adoption of wearable urology devices to monitor bladder function, increasing trend towards personalized medicine, tailoring treatment to the individual based on genetic information, can create significant opportunities for urology devices market. Growing awareness about urological health, advances in surgical technology, and growing healthcare infrastructure in emerging market, is expected to propel urology devices market growth.

Impact of Generative AI in Urology Devices Market:

• Artificial Intelligence (AI) enhances diagnostics treatment planning, and patient care, leading to improve accuracy, efficiency, and personalized medicine. AI algorithms can analyze urological images such as CT scans and ultrasounds to detect abnormalities. AI-powered wearable devices can facilitate remote monitoring of urological conditions, by reducing the need of hospitals visit. AI models can assist surgeons during surgical procedure for providing real-time guidance and improves surgical accuracy.

Key Drivers of Target Market:

Rising Research & Development Activities for the Introduction of Advanced Products is projected to drive the Market Growth

Rising research and development (R&D) activities are continuous innovations in technology to introduce advanced and effective products. R&D are focuses on improving existing urology devices and creating new solutions to provide better diagnostics solutions for kidney disorders, and urethra-related diseases. It enhances accuracy, patient outcomes and more efficient treatment comfort. The increasing demand for effective and efficient treatment of urological disorders and rising awareness among people for early diagnosis, resulting to fueled urology devices market growth.

Aging Population is predicted to Market Growth

The aging population is one of the primary drivers for the growth of the urology devices market. As the global population ages, there is a higher prevalence of age-related health issues, which are related to the urinary system and male reproductive organs. Aging adults are more experiencing chronic conditions such as kidney failure, urinary tract infections (UTIs), and bladder dysfunction, all of which require continuous or long-term management.

The demand for chronic care devices such as dialysis machines, urinary catheters, and artificial urinary sphincters is significantly expected to rise. The increasing number of elderly patients with comorbidities, such as diabetes, hypertension, and cardiovascular disease, can also makes more susceptible to urological issues. This leads to the greater adoption of urology devices to manage these conditions effectively, resulting to drive urology devices market growth.

• For instance, in October 2024, according to the data published by WHO, by 2030, 1 in 6 people in the world will be aged 60 years or over. At this time the share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion. By 2050, the world’s population of people aged 60 years and older will double (2.1 billion). The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million.

Restraints:

Lack of Skilled Professionals and High Cost Development Distract the Target Market Growth

Lack of professionals with specialized knowledge and experience in advanced technologies may restrict the growth of target market. Many advanced urology devices, such as invasive surgeries and robotic assisted procedure, require specialized training for healthcare professionals. Also, many urology devices, laser equipment and specialized diagnostics tools come with high initial cost, which can be difficult for smaller healthcare facilities, leading to distract urology devices market growth.

• Counterbalance Statements:  advances AI-driven systems for complex procedures for providing more precise guidance, by reducing the training burden on healthcare professionals. Use augmented reality and virtual reality devices to train healthcare professionals, allowing them to gain skill required for complex urology surgeries. Mass production of advanced devices can lower per-unit costs, making these technologies more affordable for healthcare facilities. Collaboration between device manufacturer and healthcare system can also reduce the initial setup costs.

Opportunities & Market Trends:

Advancement in Single-Use Cystoscopes Create Significant Market Opportunity

Advances in single-use cystoscopes represents significant opportunity for urology devices market. Single-use cystoscopes eliminate the need for reprocessing and sterilization, which can lead to cross contamination and infection. It increases flexibility and convenience of these devices resulting to improve patient comfort during cystoscopy. Single-use cystoscopes are ready for use right out of the packaging, which streamlines the process of preparing for urological procedures.

This improves operational efficiency, as medical staff can focus on patient care rather than the time-consuming task of cleaning and maintaining reusable instruments. Single-use cystoscopes help hospitals and clinics avoid delays in procedures and reduce workflow bottlenecks, enhancing overall patient throughput. These devices are affordable, and provides high-quality solutions for urological diagnostics, resulting to drive urology devices market growth.

The urology devices market is segmented into product, application, end-user and region.

By Product:

By product, urology devices is segmented into surgical instruments, devices, and consumables. The devices hold the largest devices market share. Devices contain, diagnostics devices and surgical devices are crucial for urology disorders diagnosis, treatment and surgeries. Rising incidence of urological devices, technological advancement in surgical devices such as robotic system & laser surgeries, and increasing demand for early and accurate diagnostic procedures, leading to segment’s growth in urology devices market share.

Devices is second dominating segment in market. The growing prevalence of urological disorders like urinary incontinence, benign prostatic hyperplasia (BPH), and chronic kidney diseases contribute significantly to the demand for urology devices, resulting to impel urology devices market size.

By Application:

Based on application, urology devices market is categorized into, benign prostatic hyperplasia (bph), prostate cancer, urinary stones, urinary incontinence, and others. The BPH dominates in urology devices market share. BPH is non-cancerous enlargement of the prostate gland that cause urinary symptoms and it is most common urological conations in older men. High-prevalence of BPH, and increasing research & development aimed to improve treatment devices, leading to growth of segment in urology devices market size.   

Urinary stones is the second most leading segment in market. The treatment for urinary stones often involves devices such as lithotripsy machines and stone retrieval instruments. As the incidence of kidney stones rises globally, the demand for devices used in their removal and treatment has been growing significantly, is predicable to fuel urology devices market size over the forecast period.

By End-User:

Urology devices market by end-user divided into online hospitals & clinics, dialysis centers, ambulatory clinics, and others. The hospitals & clinics hold largest urology devices market share over the forecast period. The urology-related disorder patients are first visit to hospitals. The growing adoption of urology endoscopes such as cystoscopes and ureter scopes for treatment and diagnosis of urolithiasis in hospitals, is predicted to drive urology devices market size.

Dialysis centers is second dominant segment in market. Dialysis centers play a critical role in the treatment of patients with chronic kidney disease (CKD), and it require various urology devices such as catheters, dialysis machines, and access devices. As the global incidence of kidney disease rises, the demand for urology devices in dialysis centers continues to grow, is contributes to growth of segment in urology devices market size.

Regional Insights:

Geographically, the market is studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America: This is dominating region in urology devices market share with a 34.7% share, due to increasing number of patients suffering from kidney diseases. The rising investment in healthcare infrastructure, presence of key market players in the region and growing adoption of single-use cystoscopes, resulting to drive urology devices market growth.

• U.S. Urology Devices Market Insights:

U.S. is the dominant country in the North American urology devices market share. This is due to its advanced healthcare infrastructure, high levels of healthcare spending, and a large aging population prone to urological disorders such as BPH, urinary stones, and prostate cancer. It contains presence of major global medical device manufacturers and the adoption of cutting-edge technologies in urological procedures.

Europe: This region holds second-highest urology devices market share during the forecast period. Increasing incidence of bladder disorders, urolithiasis, and urology disorders, growing approvals of urology devices by the C.E. European commission is anticipated to growth of urological devices in Europe.

• Germany Urology Devices Market Insights:

Germany is the dominant country in the European urology devices market. The country has a well-established healthcare system, and its large aging population significantly drives the demand for urological devices. It contains major global players in the urology market, contributing to its leadership in the region. Advanced healthcare services and widespread adoption of minimally invasive procedures in Germany support the market's growth.

Asia Pacific: This is fastest growing region in urology devices market size. The urology devices market share is attributed by, several factors including the increasing prevalence of urological disorders, a large aging population, rising healthcare expenditure, and advancements in medical technology.

• Japan Urology Devices Market Insights:

Japan holds the significant share in Asia Pacific region for urology devices market. Japan has one of the oldest populations in the world, which results in a high demand for urology devices, especially for conditions such as Benign Prostatic Hyperplasia (BPH) and prostate cancer. It has advanced healthcare infrastructure, high standard of medical care, and early adoption of innovative technologies make it a leader in the APAC region for urology devices market.

Urology Devices Market Report Scope:

Attribute	Details
Market Size 2025	USD 39.7 Billion
Projected Market Size 2035	USD 81.6 Billion
CAGR Growth Rate	8.2% (2025-2035)
Base year for estimation	2024
Forecast period	2025 – 2035
Market representation	Revenue in USD Billion & CAGR from 2025 to 2035
Regional scope	North America - U.S., and Canada Europe – Germany, U.K., France, Russia, Italy, Spain, Netherlands, and Rest of Europe Asia Pacific – China, India Japan, Australia Indonesia Malaysia, South Korea, and Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa – GCC, Israel South Africa, and Rest of Middle East & Africa
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends

Segmentation:

By Product:

• Surgical Instruments
  • Catheter Introducers
  • Needles & Needle Holder
  • Forceps
  • Scissor
  • Others
• Devices
  • Diagnostic Devices
    • Endoscopes
    • Urodynamic System
    • Endovision & Imaging System
    • Others
  • Surgical Devices
    • Laser & Lithotripsy Devices
    • Robotic System
    • Stents
    • Others
• Consumables

• Dialysis Consumables
• Catheters
• Surgical Dissectors
• Guidewires
• Others

By Application:

• Benign Prostatic Hyperplasia
• Prostate Cancer
• Urinary Stones
• Urinary Incontinence
• Others

By End-User:

• Hospitals & Clinics
• Dialysis Centers
• Ambulatory Clinics
• Others  

By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Russia
  • Italy
  • Spain
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • Indonesia
  • Malaysia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

The key players operating in the urology devices market include MicroLumen Inc., Boston Scientific Corporation, and others. Major companies are developing strategies, making collaboration and partnerships with other companies to develop advanced techniques, and introducing more effective technology in urology healthcare, resulting to drive urology devices market in upcoming years.

Urology Devices Market Companies:

• MicroLumen Inc
• Boston Scientific Corporation
• Coloplast Corp
• Ambu A/S
• Olympus America
• Richard Wolf GmbH
• Siemens
• Medtronic
• BD
• Baxter
• Stryker
• Dornier MedTech.
• KARL STORZ
• Cook
• Teleflex Incorporated

View an Additional List of Companies in the Urology Devices Market

• In July 2024, Asensus Surgical gained approval from U.S. Food and Drug Administration 510(k) clearance to expand the indication of its Senhance surgical robotic system to treat adult and pediatric urology patients. The Senhance System’s precision and advanced digital capabilities make it advanced for urological procedures, by offering surgeons of digital tools and smaller instrumentation.
• In April 2024, GE Healthcare launched AI-enabled urology software to enhance prostate cancer care. AI-based software feature aimed to revolution of prostate imaging, biopsies, and treatment guidance in urology. Prostate Volume Assists automates the process of determining prostate volume, precise measurements which is essential for diagnosis and managing prostate cancer diseases, including prostate cancer.
• In January 2024, Boston Scientific launched VeraVue Single-Use Flexible Cystoscope, aimed to provide healthcare professionals to diagnose and treat indication related to urinary tract. It also provides visualization of lining of the bladder and urethra, while displaying images to perform diagnostic procedure. By utilizing sterile packaged cystoscope for each patient, reduces the risk of infection from the cross contamination with reusable cystoscopes.
• In January 2024, Boston Scientific announced the agreement to acquire Axonics, Inc. for the development and commercialization of differentiated devise to treat urinary and bowel dysfunction. This acquisition expands the urology portfolio of Boston Scientific Corporation, to serve urologist with better treatment options for chronic conditions.
• In July 2023, Olympus Corporation acquired Medi-Tate Ltd., for invasive treatment for Benign Prostatic Hyperplasia (BPH). Medi-Tate’s product known as, iTind device, received approval form U.S. FDA de Novo authorization and the European CE mark. The incidence of BPH, is most common diseases in aging men and cause of lower urinary tract symptoms, thus the product aimed to supports get relief from BPH.

Analyst View:

The global aging population, and increasing incidences of age-related conditions such as BPH, urinary incontinence, and prostate cancer is leading to market growth. Advances in robotic surgery, AI, and imaging technologies for accurate diagnostics for prostate cancer, and bladder cancer, is anticipated to growth of urology devices market share in upcoming years.

More Related Reports

Cognitive Dysfunction Devices Market
Urology Supplements Market
Nephrology and Urology Devices Market
Implantable Drug Device Market
Personal Mobility Devices Market

Company Name	Boston Scientific Corporation
Headquarter	Marlborough, Massachusetts
CEO	Michael "Mike" Mahoney
Employee Count (2024)	38,000 employees